vs
GENCOR INDUSTRIES INC（GENC）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是GENCOR INDUSTRIES INC的1.5倍（$35.5M vs $23.6M），GENCOR INDUSTRIES INC净利率更高（14.6% vs -304.2%，领先318.8%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -25.0%），GENCOR INDUSTRIES INC自由现金流更多（$10.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -23.9%）
Gencor Industries Inc是一家重型基建设备制造商，主打沥青生产装置、热力燃烧系统及配套道路施工机械，主要服务北美及全球建筑市场，客户涵盖公共基建项目方和私营建筑运营商。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
GENC vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.5倍
$23.6M
营收增速更快
RXRX
高出706.7%
-25.0%
净利率更高
GENC
高出318.8%
-304.2%
自由现金流更多
GENC
多$57.5M
$-47.3M
两年增速更快
RXRX
近两年复合增速
-23.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $23.6M | $35.5M |
| 净利润 | $3.4M | $-108.1M |
| 毛利率 | 28.7% | 59.8% |
| 营业利润率 | 13.2% | -304.8% |
| 净利率 | 14.6% | -304.2% |
| 营收同比 | -25.0% | 681.7% |
| 净利润同比 | -9.8% | 39.6% |
| 每股收益（稀释后） | $0.23 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GENCRXRX
| Q4 25 | $23.6M | $35.5M | ||
| Q3 25 | $18.8M | $5.2M | ||
| Q2 25 | $27.0M | $19.2M | ||
| Q1 25 | $38.2M | $14.7M | ||
| Q4 24 | $31.4M | $4.5M | ||
| Q3 24 | $20.9M | $26.1M | ||
| Q2 24 | $25.6M | $14.4M | ||
| Q1 24 | $40.7M | $13.8M |
净利润GENCRXRX
| Q4 25 | $3.4M | $-108.1M | ||
| Q3 25 | $1.9M | $-162.3M | ||
| Q2 25 | $3.8M | $-171.9M | ||
| Q1 25 | $6.1M | $-202.5M | ||
| Q4 24 | $3.8M | $-178.9M | ||
| Q3 24 | $1.5M | $-95.8M | ||
| Q2 24 | $2.6M | $-97.5M | ||
| Q1 24 | $6.2M | $-91.4M |
毛利率GENCRXRX
| Q4 25 | 28.7% | 59.8% | ||
| Q3 25 | 24.2% | -183.8% | ||
| Q2 25 | 26.5% | -4.9% | ||
| Q1 25 | 29.7% | -48.0% | ||
| Q4 24 | 27.6% | -181.4% | ||
| Q3 24 | 25.6% | 53.7% | ||
| Q2 24 | 23.9% | 36.2% | ||
| Q1 24 | 30.3% | 19.1% |
营业利润率GENCRXRX
| Q4 25 | 13.2% | -304.8% | ||
| Q3 25 | -1.2% | -3327.6% | ||
| Q2 25 | 11.6% | -916.8% | ||
| Q1 25 | 17.0% | -1297.9% | ||
| Q4 24 | 14.7% | -4042.4% | ||
| Q3 24 | 5.9% | -377.1% | ||
| Q2 24 | 7.8% | -697.4% | ||
| Q1 24 | 17.4% | -698.4% |
净利率GENCRXRX
| Q4 25 | 14.6% | -304.2% | ||
| Q3 25 | 10.2% | -3135.3% | ||
| Q2 25 | 14.2% | -894.2% | ||
| Q1 25 | 16.0% | -1373.3% | ||
| Q4 24 | 12.1% | -3935.5% | ||
| Q3 24 | 6.9% | -367.5% | ||
| Q2 24 | 10.0% | -676.6% | ||
| Q1 24 | 15.3% | -662.4% |
每股收益（稀释后）GENCRXRX
| Q4 25 | $0.23 | $-0.17 | ||
| Q3 25 | $0.13 | $-0.36 | ||
| Q2 25 | $0.26 | $-0.41 | ||
| Q1 25 | $0.42 | $-0.50 | ||
| Q4 24 | $0.26 | $-0.56 | ||
| Q3 24 | $0.10 | $-0.34 | ||
| Q2 24 | $0.17 | $-0.40 | ||
| Q1 24 | $0.42 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $147.7M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $215.2M | $1.1B |
| 总资产 | $228.9M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资GENCRXRX
| Q4 25 | $147.7M | $743.3M | ||
| Q3 25 | $136.3M | $659.8M | ||
| Q2 25 | $136.0M | $525.1M | ||
| Q1 25 | $143.7M | $500.5M | ||
| Q4 24 | $130.1M | $594.4M | ||
| Q3 24 | $115.4M | $427.6M | ||
| Q2 24 | $116.6M | $474.3M | ||
| Q1 24 | $117.1M | $296.3M |
总债务GENCRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | $0 | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | $0 | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益GENCRXRX
| Q4 25 | $215.2M | $1.1B | ||
| Q3 25 | $211.8M | $1.0B | ||
| Q2 25 | $209.9M | $919.1M | ||
| Q1 25 | $206.1M | $933.9M | ||
| Q4 24 | $200.0M | $1.0B | ||
| Q3 24 | $196.1M | $524.6M | ||
| Q2 24 | $194.7M | $584.4M | ||
| Q1 24 | $192.1M | $401.2M |
总资产GENCRXRX
| Q4 25 | $228.9M | $1.5B | ||
| Q3 25 | $222.6M | $1.4B | ||
| Q2 25 | $220.2M | $1.3B | ||
| Q1 25 | $223.9M | $1.3B | ||
| Q4 24 | $218.2M | $1.4B | ||
| Q3 24 | $208.1M | $726.5M | ||
| Q2 24 | $201.8M | $775.9M | ||
| Q1 24 | $206.0M | $557.8M |
负债/权益比GENCRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.00× | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | 0.00× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $11.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $10.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 43.0% | -133.1% |
| 资本支出强度资本支出/营收 | 4.1% | 3.5% |
| 现金转化率经营现金流/净利润 | 3.23× | — |
| 过去12个月自由现金流最近4个季度 | $-3.2M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流GENCRXRX
| Q4 25 | $11.1M | $-46.1M | ||
| Q3 25 | $-275.0K | $-117.4M | ||
| Q2 25 | $-23.9M | $-76.4M | ||
| Q1 25 | $12.4M | $-132.0M | ||
| Q4 24 | $14.8M | $-115.4M | ||
| Q3 24 | $-3.2M | $-59.2M | ||
| Q2 24 | $-1.0M | $-82.2M | ||
| Q1 24 | $11.7M | $-102.3M |
自由现金流GENCRXRX
| Q4 25 | $10.1M | $-47.3M | ||
| Q3 25 | $-1.3M | $-117.6M | ||
| Q2 25 | $-24.4M | $-79.6M | ||
| Q1 25 | $12.3M | $-133.8M | ||
| Q4 24 | $14.5M | $-116.7M | ||
| Q3 24 | $-3.3M | $-63.8M | ||
| Q2 24 | $-1.4M | $-83.4M | ||
| Q1 24 | $11.7M | $-109.0M |
自由现金流率GENCRXRX
| Q4 25 | 43.0% | -133.1% | ||
| Q3 25 | -6.8% | -2272.5% | ||
| Q2 25 | -90.4% | -413.9% | ||
| Q1 25 | 32.2% | -907.4% | ||
| Q4 24 | 46.1% | -2567.7% | ||
| Q3 24 | -15.8% | -244.6% | ||
| Q2 24 | -5.6% | -578.5% | ||
| Q1 24 | 28.7% | -789.9% |
资本支出强度GENCRXRX
| Q4 25 | 4.1% | 3.5% | ||
| Q3 25 | 5.4% | 4.7% | ||
| Q2 25 | 1.8% | 16.4% | ||
| Q1 25 | 0.4% | 12.4% | ||
| Q4 24 | 1.0% | 28.6% | ||
| Q3 24 | 0.4% | 17.5% | ||
| Q2 24 | 1.5% | 8.2% | ||
| Q1 24 | 0.0% | 48.2% |
现金转化率GENCRXRX
| Q4 25 | 3.23× | — | ||
| Q3 25 | -0.14× | — | ||
| Q2 25 | -6.24× | — | ||
| Q1 25 | 2.04× | — | ||
| Q4 24 | 3.88× | — | ||
| Q3 24 | -2.22× | — | ||
| Q2 24 | -0.41× | — | ||
| Q1 24 | 1.87× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
